Marinus Pharmaceuticals (NASDAQ:MRNS) Earnings Information
Marinus Pharmaceuticals last released its quarterly earnings results on November 9th, 2020. The biopharmaceutical company reported ($0.51) EPS for the quarter, topping analysts' consensus estimates of ($0.60) by $0.09. Marinus Pharmaceuticals has generated ($3.96) earnings per share over the last year. Marinus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 15th, 2021 based off prior year's report dates.
Marinus Pharmaceuticals Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Marinus Pharmaceuticals (NASDAQ:MRNS) Earnings Estimates
2021 EPS Consensus Estimate: ($1.77)
Marinus Pharmaceuticals (NASDAQ MRNS) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)